A category that didn't really exist as a supermarket presence ten years ago is now one of the fastest-growing parts of UK soft drinks. Understanding why matters, partly because the trajectory is unusual, and partly because the underlying consumer behaviour has more durability than the typical wellness boom.
The headline numbers, where they can be pinned down. The UK functional beverages market sits at roughly £2.2 billion in 2026 according to IBISWorld's latest UK industry report; broader projections from Market Research Future put the figure at around USD 6.76 billion in 2025 and forecast growth to USD 10 billion by 2035, a compound annual rate of about 3.9%. Globally, the picture is bigger and faster. FoodNavigator reported in October 2025 that the global functional beverages category is on course to hit USD 250 billion by 2030, growing at roughly 8% per year. The cognitive and gut-health subcategories are growing faster than the average; gut health alone accounted for 26% of functional beverage launches between 2018 and 2022.
What's actually driving this? Several things at once, and the fact that they're independent of each other is part of why the trend has held up.
The first driver is the long decline in alcohol consumption (covered in more detail in another article in this series). UK weekly alcohol consumption has been falling since the mid-2000s, with younger drinkers leading the change. The space that opens up when people drink less alcohol doesn't get filled by water. It gets filled by drinks that occupy the same social and ritual position as alcohol: pleasant to hold, sophisticated to taste, with a function beyond hydration. Functional drinks, particularly the more flavour-forward ones, fit that gap exactly.
The second driver is the slow erosion of the energy drink category. The UK government's 2025 proposal to ban high-caffeine energy drinks for under-16s, combined with the Soft Drinks Industry Levy's reformulation pressure since 2018 and a growing public-health literature on the cardiovascular effects of high-dose caffeine plus high-dose sugar, has made the traditional energy drink format harder to sustain. Younger consumers in particular are moving toward drinks with a similar functional promise: alertness, focus, energy, but with cleaner ingredient lists and lower sugar.
The third driver is the maturation of the ingredient science. Compounds like lion's mane, L-theanine, ashwagandha, rhodiola, and the polyphenol-rich fruit extracts now have enough peer-reviewed clinical trial evidence behind them that formulators can build products around real mechanisms rather than vague wellness signalling. The 2024–2025 wave of meta-analyses on anthocyanins (n=59 RCTs in the GeroScience review), zinc and cognition, vitamin D and dementia risk, and the ginger-and-inflammation literature have all firmed up the case for several ingredients that were on the borderline of credibility a decade ago.
The fourth driver is regulatory. The UK and EU have a relatively strict framework for nutrition and health claims (the Nutrition and Health Claims Regulation, still applicable post-Brexit), which means functional drinks selling in the UK have to anchor specific claims to specific nutrients with EFSA-approved language. This raises the floor on what brands can actually say, which over time forces real ingredients into products that want to make claims at all. A drink can say "B12 supports normal cognitive function" because EFSA has authorised it. It cannot say "boosts brain power": that's outside the regulated framework.
The fifth driver is investment. PepsiCo acquired Mindful Boost, a California-based sparkling nootropic tea company, in March 2025, signalling that the major drinks corporates view the cognitive-enhancement segment as a serious growth area rather than a passing trend. Coca-Cola's portfolio additions over the last three years have included functional beverage acquisitions across the prebiotic, electrolyte, and energy-alternative categories. When the incumbents start buying, the category usually has at least another decade left in it.
So where is the UK market headed specifically? A few patterns are visible. Nootropic and cognitive-support drinks are the fastest-growing subcategory, partly because the underlying behaviours (more remote work, more screen time, more demand for sustained focus, less reliance on alcohol) all point in the same direction. The UK nootropic functional beverages market was valued at roughly £100 million in 2019 and is projected to more than triple by the early 2030s.
Gut-health drinks (kombuchas, prebiotic fibre drinks, kefirs) are growing fast and may overtake cognitive in volume, though the cognitive segment is denser per unit (higher-value products, more complex formulations).
Low-and-no alcohol drinks with a functional layer (alcohol-free with added botanicals, vitamins, or adaptogens) are starting to merge with the functional drinks category proper. The line between "non-alcoholic premium drink" and "functional drink" is blurring in the UK supermarket aisle.
What's likely to slow this growth is the standard set of category problems: mediocre formulations chasing the trend, brands "fairy-dusting" trendy ingredients at sub-clinical doses, regulatory pushback on over-claiming, and consumer fatigue if products underdeliver. The brands that survive will be the ones whose formulations actually do what the label says. The ones that don't will follow the same trajectory as a lot of 2010s health-food fads: initial growth, plateau, decline.
This is the context COG sits in: in the cognitive support corner of the functional drinks market. The category is wide open. Most UK consumers haven't tried a functional drink yet. The trajectory of the next ten years suggests that's going to change.
